Turn Therapeutics Inc. Stock: price and insider trades · United States

Turn Therapeutics Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). 5 insiders have disclosed 15 filings since 18 October 2025.

The flow runs one way only: 3 insiders bought (8 purchases totalling €263k) and nobody sold on the market. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 senior executive. The largest single trade was a purchase of €86k by Golden Arthur F, published on 23 October 2025.

Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 15 filings, this issuer sits below that mark. The full history, which starts in 2025, counts 8 purchases against no sales.

Within a 30-day window, 8 purchases overlapped with buying by a second insider. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The latest purchase dates back some time: it was published 310 days ago, on 12 December 2025. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4.

Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.